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Introduction
Certain autonomous parvoviruses and their derivates are
currently under evaluation as antitumor vectors since they
preferentially replicate and kill in vitro-transformed cells
and may reduce the incidence of spontaneous and
implanted tumors in animals. However, their oncolytic
properties are not yet fully understood and seem to
involve more than tumor cell killing. H1-mediated tumor
cell lysates may trigger antigen presenting cells to augment
host immune responses. Therefore, we analysed matura-
tion, activation and crosspresentation of dendritic cells
(DC) after phagocytosis of H1-induced tumor cell lysates
using the known human SK29-Mel melanoma cell model.
Methods
For detection of cell death Annexin V/Propidiumjodide
assay in FACscan analysis was used. To analyse phagocy-
tosis by DC PKH-2 stained immature DC were cocultured
with PKH-26 stained H1-, UV- induced or freeze thaw
cycled (and combinations of these) melanoma cells and
quantified via FACscan and fluorescence microscopy.
Comparably, FACscan was used for the analysis of DC
maturation and activation. DC were labeled with CD45-
FITC, CD14-, CD80-, CD83-, CD86-PE and 7-AAD. Cross-
presentation of tumor cell antigens to CTL via DC were
detected by IFNγ-release with a HLA-A2 negative subclone
of SK29Mel-1.
Results
We first established that the HLA-A2 positive (SK29-Mel-
1) and an HLA-A2 negative (SK29Mel-1.22) melanoma
cell lines were equally susceptible to H1-induced cell kill-
ing. Secondly, we found that monocyt-derived, immature
DC pagocytosed H1-mediated lysates better than mechan-
ically destroyed cells. These DC were more perceptive to
late than to early H1 infected cell lysates. DC cocultured
with late apoptotic H1-induced SK29Mel cells presented
typical markers of maturation and activation. Further-
more SK29Mel-1.22 activated DC confirmed crosspresen-
tation to autologoues CTL.
Conclusion
We revealed to the first time that parvovirus-induced
tumor cell killing stimulates DC and CTL. The immune
system may rapidly detect and respond to H1-infected
tumors, thus making the clinical perspectives of parvovi-
ral vectors even more promising
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